Characterization of Post-Consumer PET after Removal of the Original Surface: Influence of Raw Material

Post-consumer cooking oil and soft drink PET bottles (PEToil and PETsoft drink) were ground and washed only with water (conventional washing). The polymer was then chemically washed (10min in an aqueous solution of sodium hydroxide 5mol center dot L-1 at 90 degrees C) and rinsed. The materials before and after chemical washing were characterized by intrinsic viscosity, differential scanning calorimetry, thermogravimetry, elemental analysis, scanning electron microscopy with X-ray spectrum microanalysis, and gas chromatography coupled to mass spectrometry. The results indicated that conventionally washed PEToil is the material that most differs among the four tested ones, and that the other three are more similar to each other and to what is expected for pure PET. For example, the composition of PEToil washed only in water contained 30 volatile organic compounds, 5 nonvolatile compounds, and 7 metals, while PETsoft drink washed conventionally and chemically contained 5 volatile organic compounds and no metal or nonvolatile organic compounds.

Effects of 15d-PGJ(2)-loaded poly(D,L-lactide-co-glycolide) nanocapsules on inflammation

BACKGROUND and PURPOSEThe PPAR-gamma agonist 15d-PGJ(2) is a potent anti-inflammatory agent but only at high doses. To improve the efficiency of 15d-PGJ(2), we used poly(D,L-lactide-co-glycolide) nanocapsules to encapsulate it, and function as a drug carrier system. The effects of these loaded nanocapsules (15d-PGJ(2)-NC) on inflammation induced by different stimuli were compared with those of free 15d-PGJ(2).EXPERIMENTAL APPROACHMice were pretreated (s.c.) with either 15d-PGJ(2)-NC or unloaded 15d-PGJ(2) (3, 10 or 30 mu g center dot kg-1), before induction of an inflammatory response by i.p. injection of either endotoxin (LPS), carrageenan (Cg) or mBSA (immune response).KEY RESULTSThe 15d-PGJ(2)-NC complex did not display changes in physico-chemical parameters or drug association efficiency over time, and was stable for up to 60 days of storage. Neutrophil migration induced by i.p. administration of LPS, Cg or mBSA was inhibited by 15d-PGJ(2)-NC, but not by unloaded 15d-PGJ(2). In the Cg model, 15d-PGJ(2)-NC markedly inhibited serum levels of the pro-inflammatory cytokines TNF-alpha, IL-1 beta and IL-12p70. Importantly, 15d-PGJ(2)-NC released high amounts of 15d-PGJ(2), reaching a peak between 2 and 8 h after administration. 15d-PGJ(2) was detected in mouse serum after 24 h, indicating sustained release from the carrier. When the same concentration of unloaded 15d-PGJ(2) was administered, only small amounts of 15d-PGJ(2) were found in the serum after a few hours.CONCLUSIONS and IMPLICATIONSThe present findings clearly indicate the potential of the novel anti-inflammatory 15d-PGJ(2) carrier formulation, administered systemically. The formulation enables the use of a much smaller drug dose, and is significantly more effective compared with unloaded 15d-PGJ(2).